Combretastatin A-4 phosphate
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for Combretastatin A-4 phosphate, covering 2011-11-01 to 2025-03-24. Get the full timeline:
Most recent: Clinical Trial Update: FOCUS: PCC + Bevacizumab + CA4P Versus PCC + Bevacizumab + Placebo for Subjects With Platinum Resistant Ovarian Cancer [Phase 2, Phase 3]